ViaNautis

About:

ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.

Website: https://vianautis.com/

Top Investors: Eli Lilly, Abcam, Meltwind Advisory, BGF Ventures, O2h Ventures

Description:

ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers such as the blood-brain barrier (BBB). PolyNaut, a versatile nano-engineered polymer technology that facilitates intracellular delivery, is used in collaboration with a number of partners. SomaServe is breaking new ground in the development of medications that can bypass various biological barriers and provide significant therapeutic benefits thanks to this technology.